Assertion: overactive bladder | /r/HasProperty | based on the approval of vibegron
Facets:
Source sentences:
text: The analyst cites his conviction for a positive readout in patients with overactive bladder based on the approval of vibegron in Japan and also points to Astellas' Myrbetriq, which is a drug from the same class as that of Urovant, being commercially available in the U.S.